117 related articles for article (PubMed ID: 30799801)
1. Exploration of the Effect and Mechanism of ShenQi Compound in a Spontaneous Diabetic Rat Model.
Liu Y; Kang J; Gao H; Zhang X; Chao J; Gong G; Yuan H; Xie C
Endocr Metab Immune Disord Drug Targets; 2019; 19(5):622-631. PubMed ID: 30799801
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Protective Effect of ShenQi Compound on Skeletal Muscle in Diabetic Macrovasculopathy Mice.
Duan Y; Gao H; Su H; Liu A; Liu Y; Yuan H; Xie C
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):943-951. PubMed ID: 32096754
[TBL] [Abstract][Full Text] [Related]
3. Exploration of SQC Formula Effect on Type 2 Diabetes Mellitus by Whole Transcriptome Profile in Rats.
Fu X; Zhou X; Liu Y; Lei Y; Xie H; Leng Y; Gao H; Xie C
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1261-1269. PubMed ID: 33632114
[TBL] [Abstract][Full Text] [Related]
4. [Effects of shenqi compound on the mRNA expression of AT1R in the aorta of GK rats].
Zhuang C; Xie CG; Chen M; Liu Y; Gao H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Mar; 33(3):351-5. PubMed ID: 23713249
[TBL] [Abstract][Full Text] [Related]
5. Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites.
Zhang X; Wang H; Xie C; Hu Z; Zhang Y; Peng S; He Y; Kang J; Gao H; Yuan H; Liu Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123189. PubMed ID: 35219959
[TBL] [Abstract][Full Text] [Related]
6. Preliminary Study of the Distinctive Mechanism of Shenqi Compound in Treating Rats with Type 2 Diabetes Mellitus by Comparing with Metformin.
Fu X; Zhou X; Liu Y; Lei Y; Xie H; Leng Y; Gao H; Xie C
Curr Vasc Pharmacol; 2023; 21(2):120-127. PubMed ID: 36752289
[TBL] [Abstract][Full Text] [Related]
7. The protective role of shenqi compound in type 2 diabetes: A comprehensive investigation of pancreatic β-cell function and mass.
Yang C; Liu H; Xie Z; Yang Q; Du L; Xie C
Biomed Pharmacother; 2023 Oct; 166():115287. PubMed ID: 37572639
[TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese medicine Shenqi compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: Study protocol for a randomized controlled multicenter trial.
Zhu Q; Kang J; Xu G; Li J; Zhou H; Liu Y
Medicine (Baltimore); 2020 Mar; 99(11):e19501. PubMed ID: 32176092
[TBL] [Abstract][Full Text] [Related]
9. Effect of siglidine on glucose lipid metabolism and the expression of iNOS and GLP-1 receptors in diabetic rats.
Zhang HY; Li Y; Zhong YH; Ruan LB; Yang TR; Yin HP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8984-8989. PubMed ID: 30575943
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Shenqi compound on PTEN/PI3K signal transduction in GK rats with diabetes mellitus macroangiopathy].
Liu Y; Xie CG; Chen M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jun; 30(6):640-4. PubMed ID: 20815283
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and mechanism of Shenqi Compound in inhibiting diabetic vascular calcification.
Yang C; Xie Z; Liu H; Wang X; Zhang Z; Du L; Xie C
Mol Med; 2023 Dec; 29(1):168. PubMed ID: 38093172
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules.
Gao H; Duan Y; Fu X; Xie H; Liu Y; Yuan H; Zhou M; Xie C
PLoS One; 2018; 13(12):e0207683. PubMed ID: 30521536
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical, apoptotic and biochemical changes by dipeptidyl peptidase-4 inhibitor-sitagliptin in type-2 diabetic rats.
Karabulut S; Coskun ZM; Bolkent S
Pharmacol Rep; 2015 Oct; 67(5):846-53. PubMed ID: 26398375
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
[TBL] [Abstract][Full Text] [Related]
16. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
17. The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats.
Han X; Yang Y; Metwaly AM; Xue Y; Shi Y; Dou D
J Ethnopharmacol; 2019 Jul; 239():111942. PubMed ID: 31075380
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking.
Ramírez E; Picatoste B; González-Bris A; Oteo M; Cruz F; Caro-Vadillo A; Egido J; Tuñón J; Morcillo MA; Lorenzo Ó
Cardiovasc Diabetol; 2018 Jan; 17(1):12. PubMed ID: 29325553
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats.
Xu Z; Ju J; Wang K; Gu C; Feng Y
J Ethnopharmacol; 2014; 151(1):548-55. PubMed ID: 24269245
[TBL] [Abstract][Full Text] [Related]
20. Employing observational method for prospective data collection: A case study for analyzing diagnostic process and evaluating efficacy of TCM treatments for diabetes mellitus.
Gu X; Huang N; Gu J; Joshi MK; Wang H
J Ethnopharmacol; 2016 Nov; 192():516-523. PubMed ID: 27616025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
